PACIFIC BIOSCIENCES OF CALIF (PACB) Stock Income Statement
NASDAQ:PACB - Nasdaq - US69404D1081 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 152.36M | 154.01M | 200.52M | 128.30M | 130.50M | |||
| Cost Of Goods | 122.66M | 115.73M | 144.31M | 75.60M | 71.70M | |||
| Gross Profit | 29.70M | 38.28M | 56.22M | 52.70M | 58.90M | |||
| Operating Expenses | 620.61M | 306.30M | 378.20M | 356.20M | 238.10M | |||
| Research and Development | 112.52M | 129.02M | 187.17M | 193.00M | 112.90M | |||
| Selling, General, and Administrative Expenses | 153.03M | 160.12M | 169.82M | 160.90M | 124.10M | |||
| Operating Income | -590.92M | -268.01M | -321.99M | -303.50M | -179.30M | |||
| Interest Income/Expense | -11.57M | -13.41M | -14.34M | -14.70M | -12.50M | |||
| Other Income/Expense | 21.32M | 23.78M | 32.68M | 7.60M | 100.00K | |||
| Non Recurring Items | -76.56M | -51.89M | -14.51M | -3.70M | -83.10M | |||
| Income Before Taxes | -657.73M | -309.54M | -318.16M | -314.20M | -274.90M | |||
| Income Tax | 14.00K | 316.00K | -11.42M | 0.00 | -93.60M | |||
| Net Income | -657.75M | -309.85M | -306.74M | -314.20M | -181.20M | |||
| EBITDA | -188.31M | -226.83M | -302.26M | -293.11M | -171.72M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.29 | -1.13 | -1.21 | -1.40 | -0.89 | |||
| Non GAAP EPS | -2.79 | -1.64 | -1.21 | -1.40 | -1.20 | |||
| Statistics | ||||||||
| Gross Profit Margin | 19.49% | 24.85% | 28.03% | 41.08% | 45.13% | |||
| Profit Margin | -431.71% | -201.18% | -152.97% | -244.89% | -138.85% | |||
| Operating Profit Margin | -387.85% | -174.02% | -160.58% | -236.55% | -137.39% | |||
All data in USD